{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:19:10Z","timestamp":1791001150978,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Valneva"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Lyme borreliosis (LB) is the most common vector-borne disease in Europe. Research on factors that shape LB risk perception in Europe is limited. This study explores the potential drivers of LB risk perception in the general adult (18\u201365 years) population of twenty European countries, such as urbanicity, socioeconomic status, dog ownership, gender, age, and tick and LB diagnosis history.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data were obtained from a 2022 survey of 28,034 adults aged 18\u201365 years in twenty European countries. The survey included questions on knowledge, attitudes, and practices related to ticks and LB. Respondents were categorized into three income levels (low, middle, or high) based on country-specific income tertiles. Descriptive statistics were calculated, and differences in responses to survey items by income level were assessed using chi-square tests. Risk perception was measured from a survey question asking respondents to rate their risk of contracting LB on a five-point scale from \u201cvery low risk\u201d to \u201cvery high risk.\u201d Ordinal logistic regression modeled the relationship between predictor variables and LB risk perception.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Having a past LB diagnosis (adjusted odds ratio [AOR]: 3.96, 95% confidence interval [CI]: 3.38\u20134.64) was most strongly tied to increased LB risk perception. Knowing someone with a past LB diagnosis or having a past tick bite, were also significantly associated with higher risk perception (AOR: 2.11, 95% CI: 1.97\u20132.27, and AOR: 1.71, 95% CI: 1.60\u20131.84, respectively). High-income respondents were most likely to report a past tick bite (55.4%, 95% CI: 53.5\u201357.3%) and a past LB diagnosis (13.5%, 95% CI: 12.1\u201314.8%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Experience with ticks and LB (i.e., via bites or diagnoses) may play a key role in shaping LB risk perception among European adults. Dog ownership and demographic factors such as gender and age may also influence LB risk perception. These results could help LB educational campaigns addressing knowledge and perception gaps.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-23722-z","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T06:36:01Z","timestamp":1754030161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors influencing Lyme borreliosis risk perception in Europe: a cross-sectional multi-country survey study"],"prefix":"10.1186","volume":"25","author":[{"given":"Emily","family":"Colby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Hannah","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Brestrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Moisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"23722_CR1","unstructured":"Lindren E, Jaenson T. Lyme borreliosis in Europe: Influences of Climate and Climate Change, Epidemiology, Ecology and Adaptation Measures. Geneva: World Health Organization; 2006."},{"issue":"4","key":"23722_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/vbz.2022.0071","volume":"23","author":"L Burn","year":"2023","unstructured":"Burn L, et al. Incidence of Lyme borreliosis in Europe from National surveillance systems (2005\u20132020). Vector Borne Zoonotic Dis. 2023;23(4):156\u201371.","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"3","key":"23722_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/17843286.2019.1694293","volume":"76","author":"O Vandekerckhove","year":"2021","unstructured":"Vandekerckhove O, De Buck E, Van Wijngaerden E. Lyme disease in Western europe: an emerging problem? A systematic review. Acta Clin Belg. 2021;76(3):244\u201352.","journal-title":"Acta Clin Belg"},{"issue":"4","key":"23722_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/vbz.2022.0067","volume":"23","author":"A Nagarajan","year":"2023","unstructured":"Nagarajan A, et al. The landscape of Lyme borreliosis surveillance in Europe. Vector Borne Zoonotic Dis. 2023;23(4):142\u201355.","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"4","key":"23722_CR5","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/jme\/tjaa209","volume":"58","author":"MA Diuk-Wasser","year":"2021","unstructured":"Diuk-Wasser MA, VanAcker MC, Fernandez MP. Impact of land use changes and habitat fragmentation on the Eco-epidemiology of Tick-Borne diseases. J Med Entomol. 2021;58(4):1546\u201364.","journal-title":"J Med Entomol"},{"issue":"1","key":"23722_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1186\/s12889-024-18348-6","volume":"24","author":"JJ Logan","year":"2024","unstructured":"Logan JJ, et al. Knowledge, protective behaviours, and perception of Lyme disease in an area of emerging risk: results from a cross-sectional survey of adults in ottawa, Ontario. BMC Public Health. 2024;24(1):867.","journal-title":"BMC Public Health"},{"issue":"12","key":"23722_CR7","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.3390\/vaccines10122163","volume":"10","author":"M Wozinska","year":"2022","unstructured":"Wozinska M, et al. Knowledge, attitudes, and behaviors regarding Lyme borreliosis prevention in the endemic area of Northeastern Poland. Vaccines (Basel). 2022;10(12):2163.","journal-title":"Vaccines (Basel)."},{"key":"23722_CR8","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1186\/1471-2458-14-1298","volume":"14","author":"C Aenishaenslin","year":"2014","unstructured":"Aenishaenslin C, et al. From Lyme disease emergence to endemicity: a cross sectional comparative study of risk perceptions in different populations. BMC Public Health. 2014;14:1298.","journal-title":"BMC Public Health"},{"issue":"6","key":"23722_CR9","doi-asserted-by":"publisher","first-page":"101264","DOI":"10.1016\/j.ttbdis.2019.07.008","volume":"10","author":"S Niesobecki","year":"2019","unstructured":"Niesobecki S, et al. Knowledge, attitudes, and behaviors regarding tick-borne disease prevention in endemic areas. Ticks Tick Borne Dis. 2019;10(6):101264.","journal-title":"Ticks Tick Borne Dis"},{"key":"23722_CR10","doi-asserted-by":"crossref","unstructured":"Bille RA, Jensen KE, Buitenwerf R. Global patterns in urban green space are strongly linked to human development and population density. Urban For Urban Green. 2023;86:127980.","DOI":"10.1016\/j.ufug.2023.127980"},{"issue":"8","key":"23722_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/ijerph14080916","volume":"14","author":"E Hoffimann","year":"2017","unstructured":"Hoffimann E, Barros H, Ribeiro AI. Socioeconomic inequalities in green space quality and Accessibility-Evidence from a Southern European City. Int J Environ Res Public Health. 2017;14(8):916.","journal-title":"Int J Environ Res Public Health."},{"key":"23722_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2458-13-225","volume":"13","author":"DJ Beaujean","year":"2013","unstructured":"Beaujean DJ, et al. Study on public perceptions and protective behaviors regarding Lyme disease among the general public in the netherlands: implications for prevention programs. BMC Public Health. 2013;13:225.","journal-title":"BMC Public Health"},{"issue":"9","key":"23722_CR13","doi-asserted-by":"publisher","first-page":"e0204609","DOI":"10.1371\/journal.pone.0204609","volume":"13","author":"YP Springer","year":"2018","unstructured":"Springer YP, Johnson PTJ. Large-scale health disparities associated with Lyme disease and human monocytic ehrlichiosis in the united states, 2007\u20132013. PLoS ONE. 2018;13(9):e0204609.","journal-title":"PLoS ONE"},{"issue":"6","key":"23722_CR14","doi-asserted-by":"publisher","first-page":"101549","DOI":"10.1016\/j.ttbdis.2020.101549","volume":"11","author":"MM Tetens","year":"2020","unstructured":"Tetens MM, et al. Changes in Lyme neuroborreliosis incidence in denmark, 1996 to 2015. Ticks Tick Borne Dis. 2020;11(6):101549.","journal-title":"Ticks Tick Borne Dis"},{"issue":"12","key":"23722_CR15","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1089\/vbz.2022.0044","volume":"22","author":"AM Slatculescu","year":"2022","unstructured":"Slatculescu AM, et al. Rurality, socioeconomic status, and residence in environmental risk areas associated with increased Lyme disease incidence in ontario, canada: A Case-Control study. Vector Borne Zoonotic Dis. 2022;22(12):572\u201381.","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"4","key":"23722_CR16","first-page":"267","volume":"54","author":"M So\u010dan","year":"2015","unstructured":"So\u010dan M, et al. Socio-Economic characteristics in notified erythema Migrans patients. Zdr Varst. 2015;54(4):267\u201373.","journal-title":"Zdr Varst"},{"issue":"7","key":"23722_CR17","doi-asserted-by":"publisher","first-page":"e028064","DOI":"10.1136\/bmjopen-2018-028064","volume":"9","author":"JSP Tulloch","year":"2019","unstructured":"Tulloch JSP, et al. The demographics and geographic distribution of laboratory-confirmed Lyme disease cases in England and Wales (2013\u20132016): an ecological study. BMJ Open. 2019;9(7):e028064.","journal-title":"BMJ Open"},{"issue":"1","key":"23722_CR18","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1186\/s12879-021-06959-y","volume":"21","author":"KA Moon","year":"2021","unstructured":"Moon KA, et al. Risk factors for Lyme disease stage and manifestation using electronic health records. BMC Infect Dis. 2021;21(1):1269.","journal-title":"BMC Infect Dis"},{"key":"23722_CR19","doi-asserted-by":"crossref","unstructured":"Gould LH, Pilz ECA, Brestrich G, Halsby K, Kelly PH, Moisi JC, Stark JH. Lyme borreliosis awareness and risk perception\u2014a survey in Twenty European countries. Epidemiol Infect. 2025;153:e29.","DOI":"10.1017\/S0950268825000068"},{"key":"23722_CR20","unstructured":"Services UD. o.H.a.H., Exemptions (2018 Requirements), in 45, U.D.o.H.a.H. Services, Editor. 225."},{"issue":"20","key":"23722_CR21","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. Declaration of helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"key":"23722_CR22","unstructured":"OECD Data Explorer Income Distribution Database, https:\/\/data-explorer.oecd.org\/. Date accessed: April 30, 2024."},{"issue":"1","key":"23722_CR23","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1186\/s12889-019-7977-5","volume":"19","author":"D Slunge","year":"2019","unstructured":"Slunge D, et al. Who is afraid of ticks and tick-borne diseases? Results from a cross-sectional survey in Scandinavia. BMC Public Health. 2019;19(1):1666.","journal-title":"BMC Public Health"},{"issue":"2","key":"23722_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.amepre.2003.10.010","volume":"26","author":"JE Herrington","year":"2004","unstructured":"Herrington JE. Risk perceptions regarding ticks and Lyme disease: a National survey. Am J Prev Med. 2004;26(2):135\u201340.","journal-title":"Am J Prev Med"},{"issue":"9","key":"23722_CR25","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.2105\/AJPH.2015.302741","volume":"105","author":"SK Greene","year":"2015","unstructured":"Greene SK, et al. Disparities in reportable communicable disease incidence by census Tract-Level poverty, new York city, 2006\u20132013. Am J Public Health. 2015;105(9):e27\u201334.","journal-title":"Am J Public Health"},{"issue":"4","key":"23722_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/vbz.2022.0050","volume":"23","author":"C Nuttens","year":"2023","unstructured":"Nuttens C, et al. Epidemiology of Lyme borreliosis in France in primary care and hospital settings, 2010\u20132019. Vector Borne Zoonotic Dis. 2023;23(4):221\u20139.","journal-title":"Vector Borne Zoonotic Dis"},{"key":"23722_CR27","doi-asserted-by":"crossref","unstructured":"Brestrich G, et al. Incidence of Lyme borreliosis in germany: A retrospective observational healthcare claims study.  Ticks Tick Borne Dis. 2024;15(3):102326.","DOI":"10.1016\/j.ttbdis.2024.102326"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23722-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23722-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23722-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:13:48Z","timestamp":1757326428000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23722-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23722"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23722-z","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey was determined exempt from institutional review board oversight by the study investigators in accordance with categories of exempt research under 45 CFR part 46.104, Exempt Research [20]. All research was compliant with the principles laid out in the Helsinki Declaration [21]. Participation in the survey questions was preceded by a notice of the voluntariness of the survey, the respondent\u2019s right to withdraw at any point, an agreement about a provision of health data, and a notice of privacy policies. Respondents were asked to check boxes to confirm their understanding and agreement before proceeding to the survey questions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of Pfizer and may hold stock or stock options.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2603"}}